After the Fed released minutes of its last meeting, the bond market signaled it fears the Fed will not be aggressive enough with its rate cutting.Market Insiderread more
The Fed minutes also note that "a couple" members wanted a 50 basis point cut, based primarily on the weak inflation readings.The Fedread more
The inversion is seen by many veteran traders as an important recession omen, though the timing on the eventual downturn is less predictable.Bondsread more
Here's what Nordstrom reported for its fiscal second-quarter earnings.Retailread more
The sexy image that once boosted Victoria's Secret has been haunting L Brands more recently, as women are steering clear of the brand's hot pink, lacy and bejeweled lingerie.Retailread more
See which stocks are posting big moves after the bell.Market Insiderread more
"I'd love to say that the optimistic universe is most likely to prevail, but the talking heads talk endlessly about how a recession is inevitable," CNBC's Jim Cramer says.Mad Money with Jim Cramerread more
Read the fine print in your Apple Card contract — one clause means you give up your right to be heard in court.Technologyread more
Federal Reserve members worried over future growth are highly concerned about the U.S.-China tariff battleThe Fedread more
President Donald Trump signed a memorandum on Wednesday to automatically cancel the student loan debt of disabled veterans. More than 25,000 service members will have their...Personal Financeread more
Jim Nussle, a former director of the Office of Management and Budget, told CNBC on Wednesday that a strong U.S. consumer is the only thing keeping the country from recession.Marketsread more
California, Hawaii, Maine and the District of Columbia filed lawsuits Monday against Purdue Pharma, bringing the total number of states accusing the OxyContin maker of helping to ignite the nationwide opioid crisis to 48.
Like those of other states, the new lawsuits accuse the privately held company and its owners, the Sackler family, of downplaying the risks of addiction to OxyContin while exaggerating its benefits. Prosecutors say the company's marketing practices encouraged doctors to push higher doses of the narcotic and contributed to a public health crisis that has caused thousands of overdoses in the U.S. each year.
"Purdue and the Sacklers traded the health and well being of Californians for profit and created an unprecedented national public health crisis in the process," California Attorney General Xavier Becerra said Monday at a news conference announcing the state's legal action. "We will hold them accountable."
OxyContin is a prescription drug used to treat moderate-to-severe pain in adults. From 1999 to 2017, nearly 218,000 people died in the United States from overdoses related to prescription opioids, according to the U.S. Centers for Disease Control and Prevention. OxyContin first came on the market in 1996.
The attorneys representing Purdue say accusations against the company are "not supported by facts and are fundamentally flawed," adding its opioid painkiller represents less than 2% of the U.S. market. They also say recent lawsuits are in many regards a repurpose of old allegations.
In a statement to CNBC on Tuesday, a spokesperson for Purdue Pharma said the company "vigorously denies the allegations contained in litigation against the company and will continue to defend itself against these misleading attacks."
The spokesperson also pointed to the dismissal of North Dakota's lawsuit against Purdue Pharma earlier this month by South Central District Judge James Hill. North Dakota Attorney General Wayne Stenehjem will appeal the dismissal.
The lawsuits come as some 1,600 cases against Purdue Pharma and other opioid manufacturers are being consolidated and transferred to a judge in the Northern District of Ohio. The cascade of lawsuits, which are expensive and show no signs of slowing any time soon, puts the company at risk of filing for Chapter 11 bankruptcy protection.
The volume of litigation is "unprecedented," said Adam Zimmerman, a professor and an expert on complex litigation at Loyola Law School in Los Angeles. He compared it to the tobacco master settlement agreement in the mid- and late-1990s in which the nation's four largest tobacco companies reached a group settlement with 46 state attorneys general.
Nebraska and Michigan are the only two states that have not sued Purdue.
In addition to the litigation, the company and the Sacklers are facing backlash from public and private institutions. CNBC reported that investment bank J.P. Morgan Chase ended its relationship with Purdue Pharma over its alleged role in the crisis. In addition, New York's Metropolitan Museum of Art and other cultural centers, which have enjoyed the Sacklers' charity over the decades, said they will no longer accept gifts from members of the family.
Correction: This story was revised to correct that Nebraska hasn't sued Purdue Pharma. An earlier version misstated one of the two states that have not sued the OxyContin maker.
— The Associated Press contributed to this report.